MEDevice Boston, an MD&M Event

September 25–26, 2024
Boston Convention and Exhibition Center,
Boston, MA
www.medeviceboston.com

MEDevice — formerly BIOMEDevice — is a meeting place for engineers and business leaders from medtech, biotech, and pharma, to inspire and collaborate on the next life-changing medical device. The event brings together suppliers showcasing the latest technologies transforming medical devices along with expert-led sessions, discussing topics from regulations to design. It also provides the opportunity to connect with industry pioneers on the latest market trends.

KEYNOTES:

Wednesday, September 25 1–2 PM • Center Stage

Diana Hall, President/CEO, ActivArmor

The Next Generation of Orthopedic Precision Medicine - Point-of-Care 3D Printed Exoskeletons

Additive manufacturing is going digital — disrupting the orthopedic market with next-generation three-dimensional body scanning, custom design, and 3D printing fabrication system. 3D printers enable providers to create bespoke devices at the point-of-care, fitted precisely to every individual’s unique body map, and customized for each patient’s unique injury or condition, use case, and lifestyle, quickly and affordably. iPhone SDK has put full-color digital scanning capability into everyone’s pockets, and automated cloud-based software gives orthopedic providers market-proven custom design capability. New material options don’t hold patients back from basic hygiene practices like showering and sanitizing their hands, or from active lifestyle activities like swimming, sweating, or getting dirty. Already in use by top hospitals like Mayo Clinic and St. Luke’s Medical Centers, and by Olympic and NFL team physicians, the digital casting revolution has already begun.

Thursday, September 26 1–2 PM • Center Stage

Kevin J. Tracey, President and CEO, Feinstein Institutes for Medical Research

Rewiring Healthcare in a Bioelectronic Future

Inflammation is a major risk factor for death and disability worldwide. However, the groundbreaking discovery of a brain, body, and immune axis via the vagus nerve inflammatory reflex enables us to treat inflammation using cutting-edge technology — replacing drugs with electrons. In this presentation, Dr. Tracey will introduce you to the vagus nerve and explain how electrical stimulation unlocks novel treatments. He will provide an overview of the current state of bioelectronic medicine, focusing on the devices, research, and clinical trial results pointing to a future state of healthcare when patients derive therapy from computerized devices delivering electrons to their nerves, instead of taking drugs.

MUST-SEE SESSIONS

Commercial Viability for Medical Devices

A key blind spot for many entrepreneurs in the medical device space is the analysis of if — and to what extent — a technology is commercially viable. Before you begin your medtech journey, you should first determine whether there is an actual market for your idea, and the various components that accompany that determination. Presented by Aidan Petrie, co-founder and managing partner at New England Medical Innovation Center, this session will guide you through a series of topics, activities, and case studies that will expose you to the key pillars that will determine your ideas market viability and commercial success. Themes explored include: what makes a technology commercially viable; key pillars for success; who cares, who pays, who uses; barriers to adoption; barriers to entry; and more.

Innovating Diagnostics: AI-Driven Biomarker Discovery for Medical Device Start-Ups

Tailored exclusively for start-ups in the medical device space, this master class zeros in on the revolutionary intersection of biomarker discovery and artificial intelligence, setting a new standard for diagnostic technologies. Entrepreneurs and innovators at the forefront of medical device development will uncover the latest advancements in biomarkers for various diseases, spotlighting their significance in the evolution of early detection, precise prognosis, and individualized treatment modalities. The heart of the session is the transformative potential of AI and machine learning in refining the discovery, validation, and integration of these biomarkers into next-generation diagnostic devices. Attendees will navigate through detailed case studies illustrating the seamless fusion of AI technologies with cutting-edge biomarker research, revealing strategies to enhance the accuracy, efficiency, and predictive power of diagnostic tools. The session is presented by Talia Haller, Life Sciences and Healthcare AI Strategy Consultant.

Strategies and Techniques to Translate from Medical Device Research into Product Development

This practical session will discuss the nuances of transitioning medical technologies from research into product development and manufacturing. It will explore the challenges of recognizing the right time to move forward, taking into account the risks associated with premature advancement. Moving too quickly can lead to wasted time and resources, necessitating additional funds, research, and time to market. The session, led by Timothy Looney, President and CEO at Northeast Biomedical, will shed light on the real-world challenges faced by management teams, who are often compelled to make decisions before the technology is ready to meet stakeholder expectations. He will address the balance between satisfying upper management and stakeholders and the associated risks. Throughout the session, he will delve into practical techniques for identifying and assessing areas of risk, enabling informed decisions on the progression of medical technology. He will also discuss the implementation of pragmatic plans and processes to mitigate these risks, aiming for a smoother path to market while improving patient outcomes. In short, this is a down-to-earth exploration of the decision-making process in medical technology development, gaining insights into optimizing the path from development to market in today’s dynamic landscape.

The Surface Pressure of Medical Device Design: Navigating Legal and Ethical Pitfalls in Privacy, Security, and Inclusivity

As part of the healthcare digitization process, medical devices and connected health solutions have become a common staple in most healthcare institutions and are used by a vast majority of patients to monitor and track their care virtually. With a projected valuation of $151 billion by 2027, the global connected health and wellness device market is poised for substantial growth, with the potential to transform patient care and reduce healthcare costs. However, the legal and ethical challenges facing medical device engineers, founders, and companies today are more complex than before the COVID-19 pandemic, with many companies struggling to understand the privacy, security, and inclusivity landscape, obligations, and best practices. Presented by Bethany Corbin, Co-founder and CEO at FemInnovation, this session delves into the world of health IT for medical devices, with a focus on helping companies understand the impact that emerging federal and state laws will have on their business models and how to develop effective compliance and risk mitigation strategies. This presentation further explores the harms and inequities that may result from the device design process and the increasing use of artificial intelligence — particularly for underserved populations — through the use of femtech case studies.